Rapid bone destruction caused by multidrug-resistant Pseudomonas aeruginosa septic arthritis: A case report

Sung Cheol Yang1, Yong In1, Saad Mohammed AlShammari2

  • 1Department of Orthopedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Medicine
|September 10, 2024
PubMed
Abstract

Insights

This case study highlights successful treatment of multidrug-resistant Pseudomonas aeruginosa knee septic arthritis using colistin and piperacillin/tazobactam. The intervention led to symptom resolution and improved knee function, demonstrating effective management of challenging infections.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Microbiology

Background:

  • Multidrug-resistant (MDR) Pseudomonas aeruginosa infections are linked to poor patient outcomes and mortality.
  • Limited antimicrobial options exist for severe MDR P. aeruginosa infections, posing treatment challenges.

Purpose of the Study:

  • To report a case of successful management of MDR P. aeruginosa septic arthritis of the knee.
  • To highlight the effectiveness of a specific antibiotic regimen in a complex clinical scenario.

Main Methods:

  • A patient with a 3-month history of knee pain and prior failed treatments presented with MDR P. aeruginosa septic arthritis.
  • Diagnosis was confirmed by culture and MRI showing significant erosive changes.
  • Treatment involved arthroscopic irrigation, synovectomy, and a 6-week course of intravenous colistin and piperacillin/tazobactam, followed by total knee arthroplasty.

Main Results:

  • The patient achieved a stable knee condition with no inflammation.
  • Significant improvement in knee range of motion (0 to 125 degrees) and near-complete pain resolution.
  • Restoration of daily living activities post-treatment.

Conclusions:

  • This case demonstrates the successful management of a challenging MDR P. aeruginosa knee infection.
  • Timely intervention and appropriate combination antibiotic therapy are crucial for favorable outcomes.
  • Highlights the need for effective treatment strategies against resistant bacterial infections.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...